Singapore scientists to start human trials of COVID-19 vaccine in August

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration

SINGAPORE (Reuters) - Singapore scientists testing a COVID-19 vaccine from U.S. firm Arcturus Therapeutics plan to start human trials in August after promising initial responses in mice.

More than 100 vaccines are being developed globally, including several already in human trials from the likes of AstraZeneca and Pfizer , to try and control a disease that has infected more than 8 million people and killed over 430,000 worldwide.